Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy

The optimal protocol for thoracic radiotherapy (TRT) in combination with chemotherapy in patients with limited-stage small-cell lung cancer (LS-SCLC) remains elusive. The present study aimed to evaluate radiation parameters in association with survival outcomes. A total of 101 patients with LS-SCLC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2020-01, Vol.19 (1), p.239-246
Hauptverfasser:	Jeong, Jae-Uk, Jeon, Wan, Ahn, Sung-Ja, Kim, Young-Chul, Oh, In-Jae, Park, Chul-Kyu, Yoon, Mee Sun, Song, Ju-Young, Nam, Taek-Keun, Chung, Woong-Ki
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapies Cancer treatment Care and treatment Chemotherapy Clinical outcomes Lung cancer Lymphatic system Magnetic resonance imaging Metastasis Multivariate analysis Oncology Patient outcomes Patients Radiation (Physics) Radiation therapy Radiotherapy Survival analysis Thoracic surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!